# A Single Centre, Prospective, Observational Study to Assess the Use of the Rehabilitation Tool, GripAble, in Patients With Upper Limb Spasticity Receiving Botulinum Toxin-A (BoNT-A) in the United Kingdom (UK).

> **NCT05169775** · — · COMPLETED · sponsor: **Ipsen** · enrollment: 16 (actual)

## Conditions studied

- Upper Limb Spasticity (ULS)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05169775
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-02
- **Primary completion:** 2023-01-04
- **Final completion:** 2023-01-04
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05169775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05169775, "A Single Centre, Prospective, Observational Study to Assess the Use of the Rehabilitation Tool, GripAble, in Patients With Upper Limb Spasticity Receiving Botulinum Toxin-A (BoNT-A) in the United Kingdom (UK).". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05169775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
